Cargando…
NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372702/ https://www.ncbi.nlm.nih.gov/pubmed/30538289 http://dx.doi.org/10.1038/s41386-018-0292-5 |
| _version_ | 1783394805769830400 |
|---|---|
| author | Rasmussen, Kurt White, David A. Acri, Jane B. |
| author_facet | Rasmussen, Kurt White, David A. Acri, Jane B. |
| author_sort | Rasmussen, Kurt |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6372702 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63727022019-06-21 NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted Rasmussen, Kurt White, David A. Acri, Jane B. Neuropsychopharmacology Comment Springer International Publishing 2018-12-07 2019-03 /pmc/articles/PMC6372702/ /pubmed/30538289 http://dx.doi.org/10.1038/s41386-018-0292-5 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Comment Rasmussen, Kurt White, David A. Acri, Jane B. NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted |
| title | NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted |
| title_full | NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted |
| title_fullStr | NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted |
| title_full_unstemmed | NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted |
| title_short | NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted |
| title_sort | nida’s medication development priorities in response to the opioid crisis: ten most wanted |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372702/ https://www.ncbi.nlm.nih.gov/pubmed/30538289 http://dx.doi.org/10.1038/s41386-018-0292-5 |
| work_keys_str_mv | AT rasmussenkurt nidasmedicationdevelopmentprioritiesinresponsetotheopioidcrisistenmostwanted AT whitedavida nidasmedicationdevelopmentprioritiesinresponsetotheopioidcrisistenmostwanted AT acrijaneb nidasmedicationdevelopmentprioritiesinresponsetotheopioidcrisistenmostwanted |